-
ACLA Comments to House HELP Committee on PAHPA Reauthorization
-
ACLA Statement on Recent HHS Announcement Regarding Regulation of Laboratory Developed Tests
Washington, D.C. – Following the recent announcement from the U.S. Department of Health and Human Services (HHS) that the U.S. Food and Drug Administration (FDA) ... Read More -
ACLA Comments Federal Health IT Strategic Plan
-
ACLA Comments CMS NPRM
-
ACLA Comments ONC NPRM
-
For patient facing mystery illness, the path to a life-changing diagnosis started with a lab test
For seven years, Cid Lopez suffered from a painful mystery illness. Worst of all, after visiting a number of specialists and undergoing multiple surgeries – ... Read More -
ACLA Response to Cures 2.0
-
ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar
Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association ... Read More -
For Seniors in Rural Communities, Erosion of Lab Benefits is an Urgent Threat
One in four seniors in the United States lives in a rural area—a notable statistic considering the unique set of health challenges these communities face. ... Read More -
AIM Coalition Letter of Support for The Promoting Integrity in Medicare Act (PIMA), H.R.2143
